Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravaginal Prasterone for Vulvovaginal Atrophy
NCT02013544Phase 3Completed
- Sponsor
- Endoceutics
- Start
- Feb 2014
- Primary completion
- Jan 2015
- Modality
- Allosteric Modulators
- Countries
- 2
01
Overview
A Phase 3 trial of prasterone in Vulvovaginal atrophy (VVA), sponsored by Endoceutics. Started Feb 2014; status: completed.
02
Drugs
prasterone
03
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT02013544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02013544.